SOLACI-CACI 2021 | Current Controversies in Post-TAVR CORONARY ACCESS – Medtronic Symposium

✔️ MEDTRONIC Symposium in the SOLACI-CACI 2021 Virtual Congress.
✔️ Topic: Current Controversies in Post-TAVR CORONARY ACCESS.

👨‍🏫 Program:

  • 00:07 – Opening – Fabrio Brito.
  • 03:03 – Resolving Coronary Access after TAVR Implantation – Oscar Millan.
  • 18:20 – Deferred Access. Acute Coronary Syndrome I in a TAVR Patient – Henrique Ribeiro.
  • 39:44 – Acute Coronary Syndrome II in a TAVR Patient – Matías Sztejfman.
  • 51:41 – Discussion: The Role of Commissural Alignment Selecting a Guidewire Tips & Tricks.
  • 57:43 – Final Comments and Closing – Fabio Brito.

👉 Moderator: Dr. Fabio Brito.
👉 Panelists: Dr. Carla Agatiello – Dr. Fabio Brito- Dr. Pablo Charry – Dr. Luis Gutiérrez – Dr. Oscar Millán – Dr. Henrique Ribeiro – Dr. Matías Sztejfman.

This event took place on August 5th, 2021.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Atrial fibrillation is associated with an increased risk of stroke and, in patients with contraindications to anticoagulation, percutaneous left atrial appendage closure represents an...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Percutaneous Mechanical Aspiration versus Surgical Treatment of Tricuspid Valve Endocarditis

Tricuspid valve infective endocarditis (TVIE) accounts for approximately 5% to 10% of all cases of infective endocarditis. Surgical treatment remains the standard therapy in...

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...